There are 3397 resources available
Innovative/novel delivery of immunotherapeutics
Presenter: Aurélien Marabelle
Session: New targets on the horizon
Resources:
Slides
Webcast
Multi-omic profiling in lymphoid neoplasms
Presenter: Iñaki Martin Subero
Session: Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
Resources:
Slides
Webcast
Invited Discussant LBA68 and LBA69
Presenter: Daniel Shao Weng Tan
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Slides
Webcast
Governmental policies to control cancer medicine prices
Presenter: Kiusiang Tay-Teo
Session: Making essential cancer drugs affordable
Resources:
Slides
Webcast
LBA70 - OSIRAM-1: A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer (TORG1833)
Presenter: Yoshiro Nakahara
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Intra-tumoural immunotherapy
Presenter: Ignacio Melero
Session: Advancing strategies for cancer immunotherapy
Resources:
Slides
Webcast
Beyond chemo and endocrine therapy
Presenter: Stephen Johnston
Session: Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer
Resources:
Slides
Webcast
Biomarker-selected therapy: Progress or delusion?
Presenter: Paul Baas
Session: Open questions in the management of mesothelioma
Resources:
Slides
Webcast
Peptide-based cancer vaccines
Presenter: Juliane Walz
Session: New targets on the horizon
Resources:
Slides
Webcast
Drug sensitivity testing in blood cancer
Presenter: Thorsten Zenz
Session: Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
Resources:
Slides
Webcast